Join Gray Plant Mooty's Jesse Berg for a CLE session sponsored by the Minnesota State Bar Association
From the MSBA: The clinical laboratory industry is facing an unprecedented level of change and uncertainty. A recently published proposed rule by CMS, pursuant to the Protecting Access to Medicare Act (PAMA), will drastically cut reimbursement rates for certain diagnostic tests and create burdensome reporting and tracking obligations for health care providers. Simultaneously, the FDA has proposed to begin, for the first time, regulating laboratory developed tests as medical devices. Our panel will explore the legal and policy issues related to PAMA, its implementation, its implications for providers, and its impact, and the FDA’s legal authority to regulate laboratory developed tests, expected legal challenges to the FDA’s jurisdiction, and legislative alternatives being considered.
Minnesota State Bar Association, Minneapolis
Gray Plant Mooty is recognized as one of the leading corporate law firms in Minnesota and one of the top franchise firms in the world. Our roots go back to 1866. Today, we are a full-service firm with nearly 180 attorneys and offices in Minneapolis and St. Cloud, Minnesota; Washington, D.C.; and Fargo, North Dakota.